Shridar Ganesan

20.3k total citations · 8 hit papers
204 papers, 12.7k citations indexed

About

Shridar Ganesan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shridar Ganesan has authored 204 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 81 papers in Oncology and 61 papers in Cancer Research. Recurrent topics in Shridar Ganesan's work include Cancer Genomics and Diagnostics (42 papers), DNA Repair Mechanisms (30 papers) and AI in cancer detection (20 papers). Shridar Ganesan is often cited by papers focused on Cancer Genomics and Diagnostics (42 papers), DNA Repair Mechanisms (30 papers) and AI in cancer detection (20 papers). Shridar Ganesan collaborates with scholars based in United States, Netherlands and India. Shridar Ganesan's co-authors include David M. Livingston, Anant Madabhushi, Ronny Drapkin, Michael D. Feldman, Gyan Bhanot, Ajay Basavanhally, John Tomaszewski, Andrew L. Kung, Thomas Jenuwein and Chryssa Kanellopoulou and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Shridar Ganesan

192 papers receiving 12.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing

2005 995 citations Shridar Ganesan et al. profile →
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

2001 978 citations Shridar Ganesan et al. profile →
X chromosomal abnormalities in basal-like human breast cancer

2006 668 citations Shridar Ganesan et al. profile →
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function

2001 541 citations Shridar Ganesan et al. profile →
Automatic detection of invasive ductal carcinoma in whole slide images with convolutional neural networks

2014 377 citations Ajay Basavanhally, Michael D. Feldman et al. profile →
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

2017 349 citations Ajay Basavanhally, Michael D. Feldman et al. Scientific Reports profile →
Understanding and overcoming resistance to PARP inhibitors in cancer therapy

2021 316 citations Shridar Ganesan, Jos Jonkers et al. profile →
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

2021 196 citations Janice M. Mehnert, Shridar Ganesan et al. profile →

Peers

Countries citing papers authored by Shridar Ganesan

Since Specialization

Citations

This map shows the geographic impact of Shridar Ganesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shridar Ganesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shridar Ganesan more than expected).

Fields of papers citing papers by Shridar Ganesan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shridar Ganesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shridar Ganesan. The network helps show where Shridar Ganesan may publish in the future.

Co-authorship network of co-authors of Shridar Ganesan

This figure shows the co-authorship network connecting the top 25 collaborators of Shridar Ganesan. A scholar is included among the top collaborators of Shridar Ganesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shridar Ganesan. Shridar Ganesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Occult collision tumor of the gastroesophageal junction comprising adenocarcinomas with distinct molecular profiles 2025 ·Cancer Genetics ·(unknown), (unknown), (unknown), Lyudmyla Berim, Shridar Ganesan, Gregory Riedlinger	1
2	A Case Series on Latissimus Dorsi Flap Reconstruction: A Versatile Approach to Managing Oncological Defects 2025 ·Cureus ·A T Nayagam, Shridar Ganesan, (unknown), (unknown), (unknown)	0
3	C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3 2025 ·Cancer Research ·(unknown), Jinhyuk Bhin, Eline van der Burg, Anne Paulien Drenth, (unknown), Catrin Lutz, (unknown), Ellen Wientjens, Sjoerd Klarenbeek, (unknown), (unknown), Stefano Annunziato, Natalie Proost, Bjørn Siteur, (unknown), Marieke van de Ven, (unknown), Shridar Ganesan, (unknown), Daniel Zingg, (unknown)	0
4	Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC 2024 ·Nature Communications ·Sukanya Panja, Mihai I. Truica, Christina Y. Yu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shridar Ganesan, Suril Gohel, Frederick D. Coffman, J. Scott Parrott, (unknown), Shantenu Jha, (unknown), Edward M. Schaeffer, Vishal Kothari, Sarki A. Abdulkadir, Antonina Mitrofanova	9
5	Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling 2024 ·Nature Biotechnology ·Rachel Yan, (unknown), (unknown), Wang Xiao, Xinhe Xue, Zoran Gajic, (unknown), (unknown), (unknown), (unknown), Ivan Raimondi, Shridar Ganesan, Eugene Katsevich, Jeffrey P. Greenfield, Nadia Dahmane, Neville E. Sanjana	5
6	Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention 2023 ·Cancer ·(unknown), Jeanne M. Ferrante, (unknown), Shridar Ganesan, Shawna V. Hudson, Coral Omene, (unknown), Anita Y. Kinney	8
7	SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity 2023 ·Oncogene ·(unknown), Wen Lu, Yong Tang, Clotilde Wiel, Yong Wei, Jian Cao, Gregory Riedlinger, Thales Papagiannakopoulos, Jessie Yanxiang Guo, Martin O. Bergö, Yibin Kang, Shridar Ganesan, Hatem E. Sabaawy, Sharon R. Pine	8
8	Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study 2023 ·JCO Precision Oncology ·(unknown), Christelle Colin, (unknown), Rahul Mhaskar, Shridar Ganesan, (unknown), Mingxiang Teng, Roohi Ismail‐Khan, Nancy Gillis	4
9	Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing 2021 ·JCO Precision Oncology ·(unknown), Israel Gomy, (unknown), Alexander Gusev, Bruce E. Johnson, Neal I. Lindeman, Laura E. MacConaill, Shridar Ganesan, Judy E. Garber, Hossein Khiabanian	9
10	Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response 2020 ·Nature Cancer ·Laura Poillet-Perez, Daniel W. Sharp, Yang Yang, Saurabh V. Laddha, Maria Ibrahim, Praveen K. Bommareddy, Zhixian Hu, Joshua A Vieth, Michael Haas, Marcus Bosenberg, Joshua D. Rabinowitz, Jian Cao, Jun‐Lin Guan, Shridar Ganesan, Chang S. Chan, Janice M. Mehnert, Edmund C. Lattime, Eileen White	78
11	Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples 2020 ·Nucleic Acids Research ·Anshuman Panda, Anupama Yadav, Huwate Yeerna, (unknown), Michael Biehl, (unknown), Alexander Schulz, (unknown), Sebastian Doniach, Hossein Khiabanian, Shridar Ganesan, Pablo Tamayo, Gyan Bhanot	19
12	All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data 2019 ·Bioinformatics ·(unknown), (unknown), (unknown), Gregory Riedlinger, Shridar Ganesan, Hossein Khiabanian	8
13	Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma 2017 ·Scientific Reports ·(unknown), Anshuman Panda, Surendra Kumar, Michael Seiler, (unknown), (unknown), Yao Ming, Grethe I.G. Alnæs, Deborah Toppmeyer, Margit Riis, Bjørn Naume, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Shridar Ganesan, Gyan Bhanot	32
14	Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers 2014 ·Molecular Cancer Research ·Saurabh V. Laddha, Shridar Ganesan, Chang S. Chan, Eileen White	157
15	Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer 2013 ·Cancer Discovery ·Yanying Huo, Hong Cai, Irina Teplova, Christian Bowman-Colin, Guanghua Chen, Sandy M. Price, Nicola Barnard, Shridar Ganesan, Vassiliki Karantza, Eileen White, Bing Xia	111
16	Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors 2012 ·Cancer Discovery ·Janneke E. Jaspers, Ariena Kersbergen, Ute Boon, Wendy Sol, Liesbeth van Deemter, Serge A.L. Zander, Rinske Drost, Ellen Wientjens, Jiuping Ji, (unknown), James H. Doroshow, Aaron Cranston, Niall M.B. Martin, Alan Lau, Mark J. O’Connor, Shridar Ganesan, Piet Borst, Jos Jonkers, Sven Rottenberg	388
17	Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma 2010 ·BMC Systems Biology ·Huiqing Liu, A. Rose Brannon, Anupama Reddy, Gabriela Alexe, Michael Seiler, Alexandra Arreola, Jay Oza, Ming Yao, David Juan, Louis S. Liou, Shridar Ganesan, Arnold J. Levine, W. Kimryn Rathmell, Gyan Bhanot	205
18	Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer 2009 ·Molecular Cancer Research ·Kevin Bray, Hsin‐Yi Chen, Cristina M. Karp, Michael May, Shridar Ganesan, Vassiliki Karantza‐Wadsworth, Robert S. DiPaola, Eileen White	41
19	Computerized Image-Based Detection and Grading of Lymphocytic Infiltration in HER2+ Breast Cancer Histopathology 2009 ·IEEE Transactions on Biomedical Engineering ·Ajay Basavanhally, Shridar Ganesan, Shannon C. Agner, James Monaco, Michael D. Feldman, J E Tomaszewski, Gyan Bhanot, Anant Madabhushi	207
20	High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates 2007 ·Cancer Research ·Gabriela Alexe, Gul S. Dalgin, Daniel Scanfeld, Pablo Tamayo, Jill P. Mesirov, Charles DeLisi, Lyndsay N. Harris, Nicola Barnard, Maritza Martel, Arnold J. Levine, Shridar Ganesan, Gyan Bhanot	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact